BSE filing, NSE: AMARDEE. Summary written from the filing by ALFA Finder's alert engine.
Amerise Biosciences Ltd: key numbers
- Share price
- ₹0.84
- Market cap
- ₹5.55 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.02 Cr
- P/E (TTM)
- -105.1×Sector 26.2×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amerise Biosciences Ltd
All →Amerise Biosciences Other Announcement
Amerise Biosciences Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulatory requirements.
Amerise Biosciences Annual General Meeting
Amerise Biosciences Limited conducted its 41st Annual General Meeting on September 24, 2026. Shareholders approved financial statements and the appointment of a new Wholetime Director and CFO.
Amerise Biosciences Annual Report
Amerise Biosciences has submitted its Annual Report for the financial year 2024-25. The company scheduled its 41st Annual General Meeting for September 24, 2026.
Amerise Biosciences Annual General Meeting
Amerise Biosciences Ltd has submitted the notice for its 41st Annual General Meeting, scheduled to be held on September 24, 2026.
Amerise Biosciences Capital Structure Change
Snehjeev Ventures Private Limited and PACs acquired 76,725 equity shares of Amerise Biosciences Ltd. The acquisition increases their aggregate stake from 10.92% to 11.04%.
Amerise Biosciences Management Change
Amerise Biosciences Limited has appointed Ms. Soni Pandiya as the new Company Secretary, replacing Ms. Minal Lakhani who resigned for better career opportunities.
Other board meeting date announcements
All →Vascon Engineers Board Meeting Date
Vascon Engineers has scheduled a board meeting on November 3, 2026 for quarterly results and NCD fund raising. Trading window stays closed until results are declared.
Ruchi Infrastructure Board Meeting Date
Ruchi Infrastructure schedules a board meeting on 4 November 2026 to approve unaudited quarterly and half-year results. Trading window remains closed until 6 November 2026.
Swastika Castal Board Meeting Date
Swastika Castal will hold a board meeting on 4 November 2026 to consider unaudited results for period ended 30 September 2026. Trading window stays closed until results.
GTL Board Meeting Date
GTL Ltd will hold a board meeting on 5 November 2026 to consider unaudited results for quarter ended 30 September 2026. Results are proposed until the meeting.
Acetech E-Commerce Board Meeting Date
Acetech E-Commerce will hold a board meeting on 03-Nov-2026 to consider a fund raise through a rights issue and other business. The trading window stays closed until 48 hours after the outcome is disseminated.
Camlin Fine Sciences Board Meeting Date
Camlin Fine Sciences' board meets on 03 Nov 2026 to consider results and a proposed rights issue. Trading window closes until 05 Nov 2026.